Profound Medical (PROF) Net Equity Issued and Repurchased (2024)
Profound Medical (PROF) posted quarterly Net Equity Issued and Repurchased of $39.2 million for Q4 2024, up 70.76% quarter-over-quarter from $22.9 million in Q1 2024.
Profound Medical (PROF) Net Equity Issued and Repurchased (2024) Analysis & Trends
Profound Medical's Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $39.2 million for Q4 2024.
- In Q4 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $39.2 million; the TTM figure through Dec 2024 stood at $62.1 million (changed N/A YoY), while the FY2025 annual figure was $42.4 million, down 31.67% from the prior year.
- Net Equity Issued and Repurchased for Q4 2024 stood at $39.2 million, up from $22.9 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $39.2 million in Q4 2024, with the low at $22.9 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Profound Medical | 247.18 Mn | 208.91 Mn | 1.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 39.17 Mn |
| Dec 31, 2024 | 39.17 Mn |
| Mar 31, 2024 | 22.94 Mn |
| Mar 31, 2024 | 22.94 Mn |